Home » Drug Information
Recently Approved Drugs
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. The database is searchable by year or by medical area. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results.
Find out more about the types of drugs included in this listing.
Year: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | [1997] | 1996 | 1995 | View By Medical Area
Baycol (cerivastatin sodium); Bayer;
Treatment for high cholesterol, Approved June 1997; withdrawn 8/8/01
Captopril and hydrochlorotiazide; Mylan Laboratories;
Generic equivalent of Capozide, Approved (tentatively) May 20, 1997
Captopril and hydrochlorotiazide; Mylan Laboratories;
Treatment for hypertension, Approved May 1997
Cardizem (R) (Diltiazem HC1 for injection) Monvial (R); Hoechst Marion Roussel;
Delivery system for Monovial, Approved September 1997
Corlopam; Neurex;
Treatment for severe high blood pressure, Approved September 1997
Diovan (valsartan); Ciba Pharmaceuticals;
Treatment for hypertension, Approved January 1997
DynaCirc CR; Novartis;
Treatment for hypertension, Approved February 1997
EDEX; Schwarz Pharma;
Treatment for erectile dysfunction, Approved June 1997
Lescol; Novartis;
Treatment for coronary atherosclerosis, Approved September 1997
Lexxel (enalapril maleate-felodipine ER); Astra Merck;
Treatment for hypertension, Approved January 1997
Microzide (hydrochlorothiazide); Watson Pharmaceuticals;
Treatment for mild-to moderate hypertension, Approved January 1997
Normiflo; Wyeth-Ayerst Laboratories;
Treatment for deep venous thrombosis, Approved May 1997
Pentoxifylline; Faulding, Mylan Laboratories;
Generic equivalent of Trental, Approved July 1997
Pindolol; Teva Pharmaceutical;
Generic equivalent of Visken, Approved April 1997
PLAVIX; Sanofi, Bristol-Myers Squibb;
Treatment for cardiac atherosclerotic events, Approved November 1997
Posicor; Roche;
Treatment for hypertension and chronic stable angina pectoris, Approved June 1997
ReoPro; Centocor;
Treatment for cardiac ischemic complications, Approved November 1997
REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals;
Generic equivalent of Pergonal, Approved February 1997
Teveten; SmithKline Beecham;
Treatment for hypertension, Approved December 1997
Verapamil; IVAX;
Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR, Approved December 1997
Warfarin Sodium tablets; Barr Laboratories;
Generic equivalent of Coumadin, Approved March 1997
Zocor; Merck;
Treatment for high cholesterol, Approved November 1997
Aphthasol; Block Drug Company;
Treatment for canker sores, Approved December 1997
Avita; Penederm;
Treatment for acne, Approved January 1997
Bactroban Cream; SmithKline Beecham;
Treatment for secondarily infected traumatic skin lesions, Approved December 1997
Clindamycin Phosphate Topical Solution USP 1%; Morton Grove Pharmaceuticals;
Generic equivalent of CLEOCIN Topical Solution 1%, Approved July 1997
Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals;
Treatment for external genital and perianal warts, Approved March 1997
Dermagraft-TC; Advanced Tissue Sciences;
Treatment for partial-thickness and severe burns, Approved October 1997
Klaron (sodium sulfacet amide lotion ) Lotion, 10%; Dermik Laboratories;
Treatment for adult acne, Approved February 1997
Mentax; Penederm;
Treatment for tinea corporis (ringworm) and tinea cruris (groin fungus), Approved January 1997
Mentax; Penederm;
Treatment for athlete's foot, Approved December 1997
Minoxidil Topical Solution 2% for Women; Alpharma;
Generic equivalent of Rogaine, Approved April 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho Pharmaceutical;
Treatment for acne in women seeking contraception, Approved January 1997
Propecia; Merck;
Treatment for male baldness, Approved December 1997
REGRANEX (becaplermin) Gel; R.W. Johnson;
Treatment for diabetic foot ulcers, Approved December 1997
Retin-A Micro (tretinoin gel) microsphere, 0.1%; Advanced Polymer Systems;
Treatment for acne, Approved February 1997
Tazorac topical gel; Allergan;
Treatment for Psoriasis, Acne Vulgaris, Approved June 1997
Baycol (cerivastatin sodium); Bayer;
Treatment for high cholesterol, Approved June 1997; withdrawn 8/8/01
Captopril and hydrochlorotiazide; Mylan Laboratories;
Generic equivalent of Capozide, Approved (tentatively) May 20, 1997
Captopril and hydrochlorotiazide; Mylan Laboratories;
Treatment for hypertension, Approved May 1997
Corlopam; Neurex;
Treatment for severe high blood pressure, Approved September 1997
Crinone 8% (progesterone gel); Wyeth-Ayerst Laboratories;
Treatment for infertile women with pregestone deficiency, Approved May 1997
Diovan (valsartan); Ciba Pharmaceuticals;
Treatment for hypertension, Approved January 1997
Dostinex Tablets (cabergoline tablets); Pharmacia & Upjohn;
Treatment of hyperprolactinemic disorders, Approved January 1997
DynaCirc CR; Novartis;
Treatment for hypertension, Approved February 1997
Effexor (R) XR (venlafaxin HCI); Wyeth-Ayerst Laboratories;
Treatment of depression, Approved October 1997
Estradiol; Duramed Pharmaceuticals;
Generic equivalent of Estrace tablets, Approved December 1997
Estradiol Tablets USP; Barr Laboratories;
Generic equivalent of Estrace, Approved October 1997
Estrostep; Warner-Lambert;
Treatment for oral contraception, Approved March 1997
Etodolac Tablets USP, 400mg; Royce Laboratories;
Generic equivalent of Lodine, Approved April 1997
Evista; Eli Lilly;
Treatment for the prevention of osteoporosis, Approved December 1997
Femara; Novartis;
Treatment for breast cancer, Approved July 1997
Follistim (TM) (follitropin beta for injection); Organon;
Treatment for infertility, Approved September 1997
Genotropin Lyophilized Powder; Pharmacia & Upjohn;
Treatment for growth hormone deficiency in adults, Approved November 1997
Geref (sermorelin acetate for injection); Serono Laboratories;
Treatment for pedicatric growth disorder, Approved October 1997
Gliadel Wafer (polifeprosan 20 with carmustine implant); Rhone-Poulenc Rorer, Guilford Pharmaceuticals;
Treatment for brain cancer, Approved February 1997
Glipizide Tablets; Duramed Pharmaceuticals;
Treatment for diabetes, Approved September 1997
Glyburide Tablets; Roche;
Treatment for blood-glucose lowering, Approved December 1997
Glyburide Tablets; Mova Pharmaceutical;
Generic version of Glynase PresTab, Approved December 1997
Gonal-F (follitropin alfa for injection); Serono Laboratories;
Treatment for infertility, Approved September 1997
Lescol; Novartis;
Treatment for coronary atherosclerosis, Approved September 1997
Lexxel (enalapril maleate-felodipine ER); Astra Merck;
Treatment for hypertension, Approved January 1997
MERIDIA; Knoll Pharmaceutical;
Treatment for obesity, Approved November 1997
Microzide (hydrochlorothiazide); Watson Pharmaceuticals;
Treatment for mild-to moderate hypertension, Approved January 1997
Norditropin (somatropin (rDNA origin) for injection); Novo Nordisk;
Treatment of children who have growth failure, Approved February 1997
Nutropin; Genentech;
Treatment for growth hormone deficiency, Approved December 1997
Pindolol; Teva Pharmaceutical;
Generic equivalent of Visken, Approved April 1997
PLAVIX; Sanofi, Bristol-Myers Squibb;
Treatment for cardiac atherosclerotic events, Approved November 1997
Posicor; Roche;
Treatment for hypertension and chronic stable angina pectoris, Approved June 1997
Prandin; Novo Nordisk;
Treatment for Type II diabetes, Approved December 1997
Prograf; Fujisawa Healthcare;
Treatment for the prevention of kidney transplant rejection, Approved April 1997
REGRANEX (becaplermin) Gel; R.W. Johnson;
Treatment for diabetic foot ulcers, Approved December 1997
REPRONEX(menotropins for injection, USP); Ferring Pharmaceuticals;
Generic equivalent of Pergonal, Approved February 1997
Skelid (tiludronate disodium); Sanofi Pharmaceuticals;
Treatment for Paget’s disease of bone, Approved March 1997
Testoderm TTS CIII; Alza;
Treatment for testosterone deficiency, Approved December 1997
Teveten; SmithKline Beecham;
Treatment for hypertension, Approved December 1997
Trazadone 150mg; Teva Pharmaceutical;
Generic equivalent of Desyrel 7, Approved May 1997
Trivora-21 and Trivora-28; Watson Pharmaceuticals;
Generic equivalents of levonorgestrel and ethinyl estradiol, Approved December 1997
Verapamil; IVAX;
Generic equivalent of Knoll's Isoptin SR and Searle's Calan SR, Approved December 1997
Zenapax; Roche;
Treatment to prevent rejection of kidney transplants, Approved December 1997
Zerit (stavudine, d4T); Bristol-Myers Squibb;
Treatment for infants and children infected with HIV, Approved January 1997
Asacol (mesalamine); Procter & Gamble;
Treatment of ulcerative colitis, Approved August 1997
Cimetadine Hydrochloride Oral Solution 300mg/5ml; Morton Grove Pharmaceuticals;
Generic equivalent of Tagamet Oral Solution, Approved October 1997
Cimetidine Hydrochloride Oral Solution; Hi-Tech Pharmacal;
Generic equivalent of Tagamet Oral Solution, 300 mg/5 ml, Approved October 1997
Prevpac; TAP Pharmaceuticals;
Treatment for duodenal ulcers, Approved December 1997
Prochloroperazine; Duramed Pharmaceuticals;
Generic equivalent of Compazine, Approved May 1997
Ranitidine Capsules; Geneva Pharmaceuticals;
Generic equivalent of Zantac GELdose, Approved October 1997
Ranitidine Tablets; Apotex;
Generic equivalent of Zantac, Approved September 1997
Urso; Axcan Schwarz;
Treatment for primary biliary cirrhosis, Approved December 1997
AGRYLIN (anagrelide HCI); Roberts Pharmaceutical;
Treatment for thrombocythemia, Approved March 1997
BENEFIX (Coagulation Factor IX--Recombinant); Genetics Institute;
Treatment for hemophilia B, Approved February 1997
Glyburide Tablets; Mova Pharmaceutical;
Generic version of Glynase PresTab, Approved December 1997
Glyburide Tablets; Roche;
Treatment for blood-glucose lowering, Approved December 1997
Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer;
Treatment for deep vein thrombosis, Approved May 1997
Neumega; Genetics Institute;
Treatment for thrombocytopenia, Approved November 1997
Rituxan; Idec Pharmaceuticals, Genentech;
Treatment for non-hodgkin's lymphoma, Approved November 1997
INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham;
Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997
Acyclovir Capsules; Teva Pharmaceutical;
Generic equivalent of Zovirax, Approved April 1997
Aldara (imiquimod); 3M Pharmaceuticals;
Treatment for external genital and perianal warts, Approved March 1997
Aphthasol; Block Drug Company;
Treatment for canker sores, Approved December 1997
Combivir; GlaxoWellcome;
Treatment for AIDS and HIV Infection, Approved September 1997
Condylox Gel 0.5% (pokofilox); Oclassen Pharmaceuticals;
Treatment for external genital and perianal warts, Approved March 1997
Famvir (famciclovir); SmithKline Beecham;
Treatment for genital herpes, Approved September 17, 1997
Flagyl ER; Searle;
Treatment for bacterial vaginosis, Approved December 1997
Flonase Nasal Spray; GlaxoWellcome;
Treatment for seasonal and perennial allergic rhinitis, Approved November 1997
Fortovase; Roche;
Treatment for HIV infection, Approved November 1997
INFERGEN (interferon alfacon-1); Amgen;
Treatment for chronic hepatitis C virus, Approved October 1997
INTRON A (Interferon alfa-2b, recombinant); Schering-Plough;
Treatment for hepatitis C, Approved March 1997
Norvir (ritonavir); Abbott Laboratories;
Treatment for HIV infection, Approved March 1996/March 1997
Rescriptor Tablets (delavirdine mesylate tablets); Pharmacia & Upjohn;
Treatment for HIV-1 infection, Approved April 1997
SPORANOX (itraconazole); Janssen Pharmaceutica;
Treatment for oral thrush, Approved March 1997
Stromectol (ivermectin); Merck;
Treatment for nondisseminated intestinal threadworm, Approved March 1997
Taxol; Bristol-Myers Squibb;
Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997
Trovan; Pfizer;
Treatment for bacterial infections, Approved December 1997
VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals;
Treatment for HIV infection in adults and children, Approved March 1997
Zerit (stavudine, d4T); Bristol-Myers Squibb;
Treatment for infants and children infected with HIV, Approved January 1997
Arthrotec; Searle;
Treatment for arthritis, Approved December 1997
Atracurium Besylate Injection; Faulding;
Generic equivalent of Tracrium, Approved April 1997
Estradiol Tablets USP; Barr Laboratories;
Generic equivalent of Estrace, Approved October 1997
Etodolac 200mg and 300mg; Royce Laboratories;
Generic equivalent of Lodine, Approved December 1997
Evista; Eli Lilly;
Treatment for the prevention of osteoporosis, Approved December 1997
Ketoprofen; Schein Pharmaceutical;
Generic equivalent or Oruvail, Approved December 1997
Skelid (tiludronate disodium); Sanofi Pharmaceuticals;
Treatment for Paget’s disease of bone, Approved March 1997
Synvisc, Synvisc-One (Hylan GF 20); Genzyme;
For the treatment of pain associated with osteoarthritis of the knee, Approved August 1997
Tolmetin Sodium; Teva Pharmaceutical;
Treatment for arthritis, Approved March 1997
EDEX; Schwarz Pharma;
Treatment for erectile dysfunction, Approved June 1997
FLOMAX; Boehringer Ingelheim;
Treatment for benign prostatic hypertrophy (BPH), Approved October 1997
Interstim Continence Control Therapy; Medtronic;
Treatment for incontinence, Approved September 1997
Prograf; Fujisawa Healthcare;
Treatment for the prevention of kidney transplant rejection, Approved April 1997
Zenapax; Roche;
Treatment to prevent rejection of kidney transplants, Approved December 1997
Bromfenac; Duract, Wyeth-Ayerst Laboratories;
Management of acute pain, Approved July 1997
Carbatrol; Elan;
Treatment for epileptic seizures and trigeminal neuralgia, Approved September 1997
Copaxone; Teva Pharmaceutical;
Treatment for relapsing-remitting multiple sclerosis, Approved January 1997
Galzin (zinc acetate); Teva Pharmaceutical;
Treatment for Wilson’s disease, Approved January 1997
Imitrex (sumatriptan); GlaxoWellcome;
Treatment for migraine headaches, Approved August 1997
Imitrex Nasal Spray; GlaxoWellcome;
Treatment for migraine, Approved November 1997
Migranal; Novartis;
Treatment for migraine headaches, Approved December 1997
Mirapex; Pharmacia & Upjohn, Boehringer Ingelheim;
Treatment for Parkinson’s Disease, Approved June 1997
NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg); Watson Pharmaceuticals;
Treatment for moderate to moderately severe pain, Approved February 1997
Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals;
Generic equivalent of Percocet and Tylox, Approved November 1997
Pramipexole; Pharmacia & Upjohn;
Treatment for Parkinson's Disease, Approved July 1997
Quadramet (Samarium Sm 153 Lexidronam Injection); DuPont Merck Pharmaceutical Company;
Treatment for pain associated with bone cancer, Approved March 1997
Requip (ropinirole hydrochloride); SmithKline Beecham;
Treatment for Parkinson's Disease, Approved September 1997
Selegiline tablets; Teva Pharmaceutical;
Generic equivalent of Eldepryl tablets, Approved January 1997
Topamax (topiramate); Ortho-McNeil Pharmaceutical;
Treatment for partial onset seizures, Approved January 1997
VERSED (midazolam HCI); Roche;
Treatment for sedating children who must undergo painful surgery, Approved March 1997
ZOMIG; Zeneca Pharmaceuticals;
Treatment for migraine, Approved November 1997
Alesse (100 mcg levonorgestrel/20 mcg ethinyl estradiol tablets); Wyeth-Ayerst Laboratories;
Treatment for the prevention of pregnancy, Approved April 1997
Crinone 8% (progesterone gel); Wyeth-Ayerst Laboratories;
Treatment for infertile women with pregestone deficiency, Approved May 1997
Estradiol; Duramed Pharmaceuticals;
Generic equivalent of Estrace tablets, Approved December 1997
Estradiol Tablets USP; Barr Laboratories;
Generic equivalent of Estrace, Approved October 1997
Estrostep; Warner-Lambert;
Treatment for oral contraception, Approved March 1997
Evista; Eli Lilly;
Treatment for the prevention of osteoporosis, Approved December 1997
Femara; Novartis;
Treatment for breast cancer, Approved July 1997
FEMSTAT One; Roche;
Treatment for vaginal yeast infections, Approved Februrary 1997
Flagyl ER; Searle;
Treatment for bacterial vaginosis, Approved December 1997
Floxin Tablets (ofloxacin tablets); Ortho-McNeil Pharmaceutical;
Treatment for pelvic inflammatory disease (PID), Approved January 1997
Follistim (TM) (follitropin beta for injection); Organon;
Treatment for infertility, Approved September 1997
Gonal-F (follitropin alfa for injection); Serono Laboratories;
Treatment for infertility, Approved September 1997
Miraluma test; DuPont Pharma Radiopharmaceuticals;
Test for breast cancer, Approved May 1997
Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Ortho Pharmaceutical;
Treatment for acne in women seeking contraception, Approved January 1997
Trivora-21 and Trivora-28; Watson Pharmaceuticals;
Generic equivalents of levonorgestrel and ethinyl estradiol, Approved December 1997
Anzemet; Hoechst Marion Roussel;
Treatment for emesis, Approved September 1997
Bromfenac; Duract, Wyeth-Ayerst Laboratories;
Management of acute pain, Approved July 1997
Femara; Novartis;
Treatment for breast cancer, Approved July 1997
Gliadel Wafer (polifeprosan 20 with carmustine implant); Rhone-Poulenc Rorer, Guilford Pharmaceuticals;
Treatment for brain cancer, Approved February 1997
Intron A; Schering-Plough;
Treatment for non-Hodgkin's lymphoma, Approved December 1997
Kytril; SmithKline Beecham;
Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997
Lupron Depot; TAP Pharmaceuticals;
Treatment for prostate cancer, Approved July 1997
Miraluma test; DuPont Pharma Radiopharmaceuticals;
Test for breast cancer, Approved May 1997
Neumega; Genetics Institute;
Treatment for thrombocytopenia, Approved November 1997
Quadramet (Samarium Sm 153 Lexidronam Injection); DuPont Merck Pharmaceutical Company;
Treatment for pain associated with bone cancer, Approved March 1997
Rituxan; Idec Pharmaceuticals, Genentech;
Treatment for non-hodgkin's lymphoma, Approved November 1997
Taxol; Bristol-Myers Squibb;
Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997
Acular; Allergan;
Treatment for post-surgical inflammation following cataract extraction, Approved November 1997
Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Allergan;
Treatment for postoperative inflammation in patients who have undergone cataract extraction, Approved January 1997
BSS Sterile Irrigating Solution; Alcon Laboratories;
Treatment during ocular surgical procedures, Approved December 1997
Floxin otic; Daiichi Pharmaceutical;
Treatment for otitis media, Approved December 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed); SmithKline Beecham;
Treatment for diphtheria, tetanus and pertussis (whooping cough) in infants and children, January 1997
AneuVysion Assay; Vysis;
Genetic test for birth defects, Approved October 1997
Antizol Injection; Orphan Medical;
Treatment for ethylene glycol poisoning, Approved December 1997
Flovent Rotadisk; GlaxoWellcome;
Treatment of asthma in patients four and older, Approved November 1997
Floxin otic; Daiichi Pharmaceutical;
Treatment for otitis media, Approved December 1997
Geref (sermorelin acetate for injection); Serono Laboratories;
Treatment for pedicatric growth disorder, Approved October 1997
Nasacort AQ (triamcinolone acetonide) Nasal Spray; Phone-Poulenc Rorer;
Treatment of nasal symptoms of seasonal allergic rhinitis in children Aged 6-11, Approved October 1997
Norditropin (somatropin (rDNA origin) for injection); Novo Nordisk;
Treatment of children who have growth failure, Approved February 1997
Norvir (ritonavir); Abbott Laboratories;
Treatment for HIV infection, Approved March 1996/March 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Tilade; Rhone Poulenc Rorer;
Treatment for asthma, Approved April 1997
Tilade (nedocromil sodium) inhaler; Rhone Poulenc Rorer;
Treatment for mild-to-moderate bronchial asthma, Approved April 1997
Timentin; SmithKline Beecham;
Treatment for septicemia, Approved December 1997
Tobi; PathoGenesis;
Treatment for cystic fibrosis, Approved December 1997
VERSED (midazolam HCI); Roche;
Treatment for sedating children who must undergo painful surgery, Approved March 1997
VIRACEPT (nelfinavir mesylate); Agouron Pharmaceuticals;
Treatment for HIV infection in adults and children, Approved March 1997
Zerit (stavudine, d4T); Bristol-Myers Squibb;
Treatment for infants and children infected with HIV, Approved January 1997
Zoloft; Pfizer;
Treatment of panic disorder in children ages 6-17, Approved October 1997
AneuVysion Assay; Vysis;
Genetic test for birth defects, Approved October 1997
Antizol Injection; Orphan Medical;
Treatment for ethylene glycol poisoning, Approved December 1997
Galzin (zinc acetate); Teva Pharmaceutical;
Treatment for Wilson’s disease, Approved January 1997
Kytril; SmithKline Beecham;
Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals;
Generic equivalent of Percocet and Tylox, Approved November 1997
Trovan; Pfizer;
Treatment for bacterial infections, Approved December 1997
Effexor (R) XR (venlafaxin HCI); Wyeth-Ayerst Laboratories;
Treatment of depression, Approved October 1997
Generic Transdermal Nicotine Patch; Sano;
Generic equivalent of Habitrol, Approved October 1997
LUVOX (fluvoxamine maleate); Solvay Pharmaceuticals, Pharmacia & Upjohn;
Treatment for obsessive compulsive disorder (OCD) in children and adolescents, Approved April 1997
Seroquel (R) (quetiapine fumarate) Tablets; Zeneca Pharmaceuticals;
Treatment for schizophrenia, Approved September 1997
Trazadone 150mg; Teva Pharmaceutical;
Generic equivalent of Desyrel 7, Approved May 1997
Zoloft; Pfizer;
Treatment for panic disorder, Approved July 1997
Zoloft; Pfizer;
Treatment of panic disorder in children ages 6-17, Approved October 1997
Zyban Sustained-Release Tablets; GlaxoWellcome;
Treatment for smoking cessation, Approved May 1997
Ceftin (cefuroxime axetil); GlaxoWellcome;
Treatment of secondary bacterial infections of acute bronchitis, Approved September 1997
Cipro; Bayer;
Treatment for acute sinusitis, Approved June 1997
Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet); Schering-Plough;
Treatment for seasonal allergy symptoms, Approved January 1997
Flonase Nasal Spray; GlaxoWellcome;
Treatment for seasonal and perennial allergic rhinitis, Approved November 1997
Flovent Rotadisk; GlaxoWellcome;
Treatment of asthma in patients four and older, Approved November 1997
Metaprotereol Sulfate Inhalation Solution, 5%; Morton Grove Pharmaceuticals;
Generic equivalent of Alupentr Inhalation Solution, 5%, Approved March 1997
Nasacort AQ (triamcinolone acetonide) Nasal Spray; Phone-Poulenc Rorer;
Treatment of nasal symptoms of seasonal allergic rhinitis in children Aged 6-11, Approved October 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Raxar (grepafloxacin); GlaxoWellcome;
Treatment for chronic bronchitis, Approved November 1997
Serevent; GlaxoWellcome;
Treatment of asthma, Approved September 1997
Tilade; Rhone Poulenc Rorer;
Treatment for asthma, Approved April 1997
Tilade (nedocromil sodium) inhaler; Rhone Poulenc Rorer;
Treatment for mild-to-moderate bronchial asthma, Approved April 1997
Tilade Nebulizer Solution; Rhone Poulenc Rorer;
Treatment for mild to moderate asthma, Approved November 1997
Tobi; PathoGenesis;
Treatment for cystic fibrosis, Approved December 1997
Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol; Schering-Plough;
Treatment for asthma, Approved January 1997
Zagam (sparfloxacin) tablets; Rhone Poulenc Rorer;
Treatment for community-acquired pneumonia (CAP) and chronic bronchitis, Approved January 1997
Zyflo (Zileuton); Abbott Laboratories;
Treatment for asthma in patients 12 years and older, Approved January 1997
Arthrotec; Searle;
Treatment for arthritis, Approved December 1997
Etodolac 200mg and 300mg; Royce Laboratories;
Generic equivalent of Lodine, Approved December 1997
Etodolac Tablets USP, 400mg; Royce Laboratories;
Generic equivalent of Lodine, Approved April 1997
Ketoprofen; Schein Pharmaceutical;
Generic equivalent or Oruvail, Approved December 1997
Synvisc, Synvisc-One (Hylan GF 20); Genzyme;
For the treatment of pain associated with osteoarthritis of the knee, Approved August 1997
Tolmetin Sodium; Teva Pharmaceutical;
Treatment for arthritis, Approved March 1997
